Teva announces positive top-line results from AJOVY clinical trials in Japan

This article was originally published here

AJOVY is under development in Japan by Otsuka Pharmaceutical Co., Ltd. (Otsuka) as part of a May 2017 exclusive license agreement for development and sales of AJOVY in

The post Teva announces positive top-line results from AJOVY clinical trials in Japan appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply